Women's Health · Founder · Operator
I'm the COO of Pendant, the only value-based care fertility benefit manager delivering greater ROI to employers and members. Across 20+ years in pharmacy, clinic, and payer operations, I've built the infrastructure that makes healthcare spend more transparent and outcomes-driven.
Innovation is only as good as the system that delivers it.
It began at Duke, where I studied biomedical engineering because I wanted to work on the systems behind people's health. I then spent ten years in global payer access and strategic pricing for large multinational pharma and biotech companies, working on what happens after the science: how new care is priced, paid for, and delivered to the people who need it.
That experience led me to build a better model. In 2016, I became employee #1 at SmithRx and had the privilege of building a pharmacy benefit manager from scratch, taking it from concept to scale on a more aligned model. I joined Kindbody to build a business within the business and left as the leader of multiple profitable business units, including pharmacy, third party, genetics, and men's health. Fertility care has advanced rapidly. The system that pays for it has not kept pace.
Today, as COO of Pendant, I am helping build the only value-based care fertility benefit manager delivering greater ROI to employers and members. I also advise women's health companies. This year, I spoke at AIFertility 2026 in Cascais, Portugal, bringing the benefit management lens to conversations on AI, accountability, and ROI in fertility.
My purpose is simple: help more families reach the advances that already exist, and build a system that is fairer to the women who depend on it. Women's health has the largest gaps, the greatest complexity, and the most room to create equity. I am grateful to work on it every day.
Designing employer fertility benefits that deliver real outcomes, across every path to parenthood, not just IVF.
How pharmacy benefit management works, where it breaks down, and what aligned PBM models actually look like in practice.
The mechanics of drug pricing, transparency, and what employers can do to stop paying for opacity they don't have to accept.
Building the operational infrastructure behind benefits: implementation, vendor management, outcomes measurement, and what good looks like at scale.
Joined the founding team to build a new kind of women's health and fertility benefits company, one designed to deliver better outcomes, greater flexibility, and greater ROI for employers and members. Pendant connects how fertility benefits are managed: member-first experience, transparent pricing, better data.
Strategic advisor to MonCap, the investment firm backing Pendant, as the company moved from concept to launch.
Nearly five years at one of the country's leading women's fertility and health companies. Rose from SVP of Pharmacy Strategy & Operations to EVP of Strategic Business Lines, leading KindRx, KindLabs, KindMan, and KindEOS, spanning pharmacy, lab, and men's health across the Kindbody ecosystem.
Hired as employee #1 to build an innovative pharmacy benefit manager (PBM) aimed at improving patient lives through a uniquely aligned business model. Led strategy, GTM/pricing, network management, implementation, plan operations, customer success, member support, and clinical services.
Reproductive health is unlike any other therapeutic area because reimbursement alone is insufficient to assess opportunity. This paper examines the impact of cultural trends, medical tourism, declining birth rates, increasing IVF access, and reforms to public policy, and what manufacturers and policymakers should understand about evolving market access environments globally.
A study of the French National Health Authority examining whether pharmaceutical manufacturers are increasingly targeting smaller oncology patient populations and the implications for market access, pricing, and reimbursement strategy.
The goal isn't more technology. It's less burden, better information, and more of the right care at the right time.
Women are 51% of the population and nearly 80% of household healthcare decisions. Yet the average employer still treats women's health as a line item. That's a business strategy failure.
For years I waited to be invited to the table. The shift came when I realized the invitation was never coming, and that was actually good news.
Not all fertility benefits are created equal. The difference between IVF coverage and actual fertility benefits is costing employees thousands, and costing employers credibility.
We tell women to find mentors. We rarely tell them to find sponsors. Here's the difference, and why it's the key driver of the leadership gap.
Women's health finally had a seat at the table at JPM this year: not a side event, not a niche panel, but part of the core dialogue. Here's what it means.
Women are the majority of healthcare consumers. The decisions made in the rooms they're not in shape what care looks like for millions. That has to change.
Bi-weekly thinking on women's health strategy and executive leadership. No noise, just signal.